{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:56:40Z","timestamp":1790603800748,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jinf.2026.106826","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:29:43Z","timestamp":1786404583000},"page":"106826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Core biomarkers and early detection criteria of cytokine storm triggered by infectious diseases: A systematic review and meta analysis"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0424-3644","authenticated-orcid":false,"given":"Junyu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1159-257X","authenticated-orcid":false,"given":"Qingkun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jinf.2026.106826_bib1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0952-7915(93)90139-J","article-title":"Cytokine dysregulation as a mechanism of graft versus host disease","volume":"5","author":"Ferrara","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2026.106826_bib3","first-page":"129","article-title":"Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule","volume":"378","author":"Oldstone","year":"2014"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1142\/S0192415X20500378","article-title":"COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease","volume":"48","author":"Chan","year":"2020","journal-title":"Am J Chin Med"},{"issue":"5","key":"10.1016\/j.jinf.2026.106826_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jinf.2026.106826_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jep.2017.10.001","article-title":"Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis","volume":"211","author":"Chen","year":"2018","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"10.1016\/j.jinf.2026.106826_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102562","article-title":"Cytokine storm syndrome in severe COVID-19","volume":"19","author":"Ruscitti","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58020144","article-title":"Cytokine Storm in COVID-19: Immunopathogenesis and Therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.jinf.2026.106826_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2026.106826_bib11","unstructured":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews - PubMed [Internet]. [cited 2025 Oct 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33782057\/."},{"issue":"9","key":"10.1016\/j.jinf.2026.106826_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"10.1016\/j.jinf.2026.106826_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2020-218479","article-title":"Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study","volume":"79","author":"Ramiro","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"10.1016\/j.jinf.2026.106826_bib14","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.3390\/ijms23147937","article-title":"Comprehensive cytokine profiling of patients with COVID-19 receiving Tocilizumab Therapy","volume":"23","author":"Lebedeva","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11886-025-02273-0","article-title":"Interleukin-6 in Cardiogenic Shock","volume":"27","author":"Fazzini","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jinf.2026.106826_bib16","article-title":"Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2026.106826_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155389","article-title":"Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients","volume":"138","author":"B\u00fclow Anderberg","year":"2021","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.jinf.2026.106826_bib18","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3390\/biomedicines9111688","article-title":"The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic","volume":"9","author":"Murdaca","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.jinf.2026.106826_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/15353702211068840","article-title":"Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?","volume":"247","author":"Liu","year":"2022","journal-title":"Exp Biol Med"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","article-title":"Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes","volume":"59","author":"Canna","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jinf.2026.106826_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"10.1016\/j.jinf.2026.106826_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101697","article-title":"The hormetic and hermetic role of IL-6","volume":"80","author":"Forcina","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00062752-200105000-00002","article-title":"Exercise and interleukin-6","volume":"8","author":"Pedersen","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ki.1993.285","article-title":"Interleukin-6 and TNF alpha production in human renal cell carcinoma","volume":"44","author":"Gogusev","year":"1993","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jinf.2026.106826_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1515\/cclm-2023-0086","article-title":"Why C-reactive protein is one of the most requested tests in clinical laboratories?","volume":"61","author":"Plebani","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.jinf.2026.106826_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10875-024-01797-4","article-title":"Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disorders","volume":"45","author":"Carol","year":"2024","journal-title":"J Clin Immunol"},{"issue":"20","key":"10.1016\/j.jinf.2026.106826_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17520363.2024.2403330","article-title":"Indices and ferritin level that predict organ involvement in adult-onset Still\u2019s disease","volume":"18","author":"Kaya","year":"2024","journal-title":"Biomark Med"},{"issue":"5","key":"10.1016\/j.jinf.2026.106826_bib29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4269\/ajtmh.20-0066","article-title":"Ferritin, Erythrocyte Sedimentation Rate, and C-Reactive protein level in patients with Chikungunya-Induced Chronic Polyarthritis","volume":"103","author":"Anna Genaro","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib30","first-page":"29","article-title":"Markers of activation of coagulation in cancer patients","volume":"124","author":"Stoencheva","year":"2023","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jinf.2026.106826_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2024.04.018","article-title":"D-dimer and risk of venous thromboembolism recurrence: comparison of two studies with similar designs but different laboratory and clinical results","volume":"238","author":"Palareti","year":"2024","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.jinf.2026.106826_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/a-1366-9656","article-title":"Prevalence and predictors of venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients","volume":"121","author":"Cohen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jinf.2026.106826_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108917","article-title":"The role of IL-10 in kidney disease","volume":"108","author":"Wei","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/1744666X.2024.2406894","article-title":"IL-10: the master immunomodulatory cytokine in allergen immunotherapy","volume":"21","author":"Liu","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"issue":"7821","key":"10.1016\/j.jinf.2026.106826_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"13","key":"10.1016\/j.jinf.2026.106826_bib37","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.7150\/ijbs.72318","article-title":"Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection","volume":"18","author":"Tayel","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jinf.2026.106826_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103622","article-title":"Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation","volume":"73","author":"Bonnet","year":"2021","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Caricchio","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jinf.2026.106826_bib40","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in Inflammation, Immunity, and Disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv098","article-title":"Acute phase reactants in infections: evidence-based review and a guide for clinicians","volume":"2","author":"Markanday","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2026.106826_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol Immunol"},{"issue":"12","key":"10.1016\/j.jinf.2026.106826_bib44","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/life13020350","article-title":"Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines","volume":"13","author":"Tsantes","year":"2023","journal-title":"Life"},{"issue":"7","key":"10.1016\/j.jinf.2026.106826_bib46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.25482","article-title":"The D-dimer assay","volume":"94","author":"Johnson","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106826_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5492\/wjccm.v11.i3.139","article-title":"Plasma D-dimer level in early and late-onset neonatal sepsis","volume":"11","author":"Al-Biltagi","year":"2022","journal-title":"World J Crit Care Med"},{"issue":"2","key":"10.1016\/j.jinf.2026.106826_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.13057","article-title":"H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome","volume":"191","author":"Ruscitti","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2026.106826_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic Syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jinf.2026.106826_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2026.106826_bib51","first-page":"1027","article-title":"The role of biomarkers in valvular heart disease: focus on natriuretic peptides","volume":"30","author":"Bergler-Klein","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jinf.2026.106826_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745515","article-title":"Basic predictive risk factors for cytokine storms in COVID-19 patients","volume":"12","author":"Shcherbak","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2026.106826_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102537","article-title":"High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients","volume":"115","author":"Iglesias-Juli\u00e1n","year":"2020","journal-title":"J Autoimmun"},{"issue":"20","key":"10.1016\/j.jinf.2026.106826_bib54","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1182\/bloodadvances.2020002592","article-title":"Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children","volume":"4","author":"Diorio","year":"2020","journal-title":"Blood Adv U S"},{"key":"10.1016\/j.jinf.2026.106826_bib55","first-page":"jiaa387","article-title":"Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2026.106826_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 Is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106826_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.29271\/jcpsp.2022.04.451","article-title":"Success of the cytokine absorption therapies in COVID-19 patients diagnosed with cytokine release syndrome","volume":"32","author":"Ozkarakas","year":"2022","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.jinf.2026.106826_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108614","article-title":"Laboratory biomarkers associated with COVID-19 severity and management","volume":"221","author":"Keddie","year":"2020","journal-title":"Clin Immunol"},{"issue":"16","key":"10.1016\/j.jinf.2026.106826_bib59","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.3390\/ijms23168879","article-title":"Cytokine Storm Signature in Patients with Moderate and Severe COVID-19","volume":"23","author":"Kalinina","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jinf.2026.106826_bib60","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S2213-2600(21)00377-5","article-title":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial","volume":"9","author":"Declercq","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jinf.2026.106826_bib61","doi-asserted-by":"crossref","unstructured":"Bozorgmehr N., Mashhouri S., Perez Rosero E., et al. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. mBio. 12(3):e00384\u201321.","DOI":"10.1128\/mBio.00384-21"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:10:50Z","timestamp":1790601050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0163445326001520"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106826","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Core biomarkers and early detection criteria of cytokine storm triggered by infectious diseases: A systematic review and meta analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106826"}}